EUVIMEDEUVIMED entdecken
Crossref

Blockade of endocannabinoid system by oxytocin attenuates memory deficits in oxycodone‐treated rats

Yu-Xiao Wan, Guang Shi, Ling-Yan Jian iD, Xin-Yu Fan iD

Addiction Biology · 2023

DOI: 10.1111/adb.13260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction Biology, 2023. Verfasst von Yu-Xiao Wan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Oxytocin, Neuropeptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Doctoral Start-up Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxycodone is a highly prescribed opioid and its abuse has been rampant. Accumulating evidence shows that the cannabinoid CB1 receptor (CB1R) plays a key role in mediating rewarding effects to opioids. However, the downstream signalling of CB1R induced by oxycodone remains unclear. The neuropeptide oxytocin is well known as a potential remedy for drug addiction. Thus, our study aims to explore the mechanism of oxycodone‐induced learning and memory deficits underlying the endocannabinoid system (ECS) and the effect of oxytocin. Rats were intraperitoneally injected with oxycodone once a day for eight consecutive day. Novel object recognition, resident‐intruder and Morris Water Maze tests were employed to assess the cognitive, social and spatial memory of the rats after oxycodone withdrawal. The (co‐)expression of CB1R, cyclin‐dependent kinase 5 (Cdk5), regulatory protein p25, tau and phosphorylated tau was measured 1 day after the last behavioural test. The histopathological staining and synaptic density in the hippocampus were observed as well. We found that oxycodone upregulated the expression of p‐GSK3β, co‐expression of p‐Cdk5 and p25 through CB1R. This finding was accompanied by elevation of pSer396, pSer404 in the tau, and reduction of the number of neurons, dendritic spines and synaptic density in the hippocampus. Furthermore, i.c.v. treatment with oxytocin ameliorates memory deficits in oxycodone‐treated rats through inhibition of the ECS. We propose further studies on the clinical use of this neuropeptide, which may potentially cure drug addiction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxytocinNeuropeptidesRatsAnimalsEndocannabinoidsOxycodoneHippocampusAnalgesics, OpioidMemory DisordersReceptors, CannabinoidReceptor, Cannabinoid, CB1

Stichwörter der Autor:innen

CB1Raddictionlearning and memoryoxycodoneoxytocin

Substanzen

OxytocinEndocannabinoidsOxycodoneAnalgesics, OpioidReceptors, CannabinoidNeuropeptidesReceptor, Cannabinoid, CB1

Autor:innen und Institutionen

  • Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Neurology, The People's Hospital of Liaoning Province, Shenyang, China.
  • Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China.

ORCID-Profile: Ling-Yan Jian, Xin-Yu Fan

Förderung

  • National Natural Science Foundation of China
  • Doctoral Start-up Foundation of Liaoning Province

Zitieren

APA

Wan, Y. X., Shi, G., Jian, L. Y., & Fan, X. Y. (2023). Blockade of endocannabinoid system by oxytocin attenuates memory deficits in oxycodone‐treated rats. Addiction Biology. https://doi.org/10.1111/adb.13260

Vancouver

Wan YX, Shi G, Jian LY, Fan XY. Blockade of endocannabinoid system by oxytocin attenuates memory deficits in oxycodone‐treated rats. Addiction Biology. 2023. doi:10.1111/adb.13260

BibTeX
@article{Wan2023,
  author = {Wan, Yu-Xiao and Shi, Guang and Jian, Ling-Yan and Fan, Xin-Yu},
  title = {Blockade of endocannabinoid system by oxytocin attenuates memory deficits in oxycodone‐treated rats},
  journal = {Addiction Biology},
  year = {2023},
  doi = {10.1111/adb.13260}
}
Kostenlos starten →